Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Science 37 Holdings, Inc. (SNCE : NSDQ)
 
 • Company Description   
Science 37 Inc. provides operating system for agile clinical trials. Science 37 Inc., formerly known as LifeSci Acquisition II Corp., is based in LOS ANGELES.

Number of Employees: 600

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.00 Daily Weekly Monthly
20 Day Moving Average: 318,271 shares
Shares Outstanding: 116.00 (millions)
Market Capitalization: $347.99 (millions)
Beta: 1.40
52 Week High: $15.10
52 Week Low: $2.79
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -33.48% -27.11%
12 Week -61.04% -57.73%
Year To Date -75.94% -71.39%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
800 PARK OFFICES DRIVE SUITE 3606
-
NORTH CAROLINA,NC 27709
USA
ph: 984-377-3737
fax: -
investors@science37.com http://www.science37.com
 
 • General Corporate Information   
Officers
David Coman - Chief Executive Officer and Director
Robert Faulkner - Chairman
Mike Zaranek - Chief Financial Officer
Adam Goulburn - Director
Adam Goulburn - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 808644108
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 116.00
Most Recent Split Date: (:1)
Beta: 1.40
Market Capitalization: $347.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.22 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.45 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.99
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 13.79%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -8.29%
ROE
03/31/22 - -95.04
12/31/21 - -146.10
09/30/21 - -1,223.14
ROA
03/31/22 - -42.91
12/31/21 - -36.79
09/30/21 - -25.59
Current Ratio
03/31/22 - 6.40
12/31/21 - 6.64
09/30/21 - 0.40
Quick Ratio
03/31/22 - 6.40
12/31/21 - 6.64
09/30/21 - 0.40
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -87.38
12/31/21 - -158.28
09/30/21 - -9.77
Book Value
03/31/22 - 1.50
12/31/21 - 1.06
09/30/21 - -0.20
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - -
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - -
 

Powered by Zacks Investment Research ©